Updated: 07 Jan 2001
Desmin® 20 | -30
Kombinationen mit Ethinylestradiol
1 Filmtbl. enth.: Ethinylestradiol 0,02 mg/0,03 mg, Desogestrel 0,15 mg/0,15 mg.
Desmin® 20/-30 Filmtabletten
The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.
The Oral Anticoagualtion Reversal Knowledge Centre is intended to provide healthcare professionals with accurate information on the approaches to oral anticoagulation reversal for patients who experience or are at risk of significant bleeding, or require surgery. Content is arranged within illustrated and referenced sections including management of bleeding risk, oral anticoagulants, symposium highlights, key publication summaries and more.
This resource is developed by EPG Health Media (Europe) Ltd for epgonline.org in collaboration with CSL Behring, with content provided by CSL Behring.
This resource is not intended for healthcare professionals outside Europe.
'alpha'-Tocopherol, Kartoffelstärke, Lactose, Magnesiumstearat, Macrogol 6000, Hypromellose, Povidon 30, Propylenglycol, Siliciumdioxid, Stearinpalmitinsäure, Desmin 20 zusätzl.: Chinolingelb (E 104).
See disease awareness facts and stats, information on sebelipase alfa (the first and only licensed treatment for LAL-D) and resources section, including expert video channel…